Stay updated with breaking news from Andreas Strungmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Two companies with local ties are leading the race for approval of a coronavirus vaccine, but this story is also so much more. It’s also about dreams raised and dashed, of billions at risk and perhaps to be made, and an unproven genetic technology that just might save the world.
The experts behind the BioNTech coronavirus jab have developed another vaccine which they claim cures multiple sclerosis (MS) in mice. The new MS vaccine works in a similar way to the coronavirus vaccine, manufactured in conjunction with US pharmaceutical giant Pfizer. A piece of genetic material known as mRNA is inserted into a person's arm and forces the body's own cells to produce a protein that confers immunity. In the case of the coronavirus vaccine, this protein mimics the virus's protruding spike, kickstarting the immune system to start making antibodies. If a person later cont...
5 days Canada May Become Leader In Booming Battery Market 6 days Nearly 42% Of All Amazon Reviews Are Fake 7 days Kidnapping Is Big Business In Nigeria 8 days COVID Fraud Amounts To Nearly $570M 10 days Art Is Now An Algorithm 11 days TikTok Threatens America, Tesla Threatens China 12 days Small-Cap Energy Sectors With Big Upside 15 days Coinbase Valued At $68 Billion Ahead Of IPO 17 days 3 Stocks To Watch Amid AstraZeneca Covid Vaccine Snafu 18 days Get Ready For First Tax Hike Since 1993 21 days Tech Majors Bet Big On Clean Energy 22 days Is T...
Ugur Sahin, CEO and founder of the German biotech firm that has teamed up with Pfizer on its vaccine, has seen share prices soar over the past year.